SIGLEC7 and colorectal carcinoma: Kensuke et al. observed a relationship between SIGLEC7 and prognosis in CRC; they found that the expression of SIGLEC7 in macrophages may become a novel prognostic biomarker for the efficacy of immunotherapy against metastatic CRC [18].